Histone deacetylase inhibitors and their use in therapy
A compound of the formula: (I) or a pharmaceutically acceptable salt thereof, wherein: L is a 5-membered nitrogen-containing heteroaryl which is optionally fused to a benzene; Y is a 5, 6 or 7-membered nitrogen-containing heteroaryl, which is optionally fused to a benzene; and W is a zinc-binding gr...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
13.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A compound of the formula: (I) or a pharmaceutically acceptable salt thereof, wherein: L is a 5-membered nitrogen-containing heteroaryl which is optionally fused to a benzene; Y is a 5, 6 or 7-membered nitrogen-containing heteroaryl, which is optionally fused to a benzene; and W is a zinc-binding group. The compounds are HDAC inhibitors and therefore have potential utility in therapy. |
---|---|
Bibliography: | Application Number: US201314441401 |